methacholine chloride
Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
PROVOCHOLINE (methacholine chloride) is an inhalation solution used as a diagnostic agent in bronchial challenge testing to assess airway hyperresponsiveness in patients with suspected asthma. It works by directly stimulating muscarinic receptors on airway smooth muscle, causing bronchoconstriction that helps clinicians identify reactive airway disease. This is a diagnostic tool rather than a therapeutic agent.
With LOE approaching on a decades-old diagnostic product, commercial teams are transitioning to defensive positioning and cost optimization rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence Study of Methacholine Chloride
A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma
PROVOCHOLINE offers limited growth career opportunities due to its mature, diagnostic-only positioning and approaching LOE. Roles on this product emphasize regulatory compliance, operational efficiency, and maintaining market access rather than commercial expansion or clinical innovation.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo